3 completed, 2 unknown. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow Cancer of Cervix: new trials by email Literature Review of Cancer of Cervix trials Research Report on Cancer of Cervix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine], Two dose, Control group - Cancer of Cervix | Phase 2 / Phase 3 | Completed | Instituto Nacional de Salud Publica, Mexico | 6000 | 2018-05-30 | 2021-12-08 |
| The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Cognitive intervention, Control group, psycho-physiological intervention - Cancer of Cervix, Ovarian Cancer | Phase 3 | Unknown | Rabin Medical Center | 60 | 2008-08-01 | 2009-02-17 |
| Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix NACT, Radical abdominal hysterectomy (class III), BPLND & lower para aortic lymph node sampling, Inj.Cisplatin - Cancer of Cervix | Phase 3 | Unknown | Tata Memorial Hospital | 635 | 2003-09-04 | 2019-09-20 |
| Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix Gemcitabine, Cisplatin, Brachytherapy - Cancer of Cervix | Phase 3 | Completed | Eli Lilly and Company | 515 | 2002-05-01 | 2009-08-11 |
| High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix HIgh Dose Rate Vs Low DOse Rate Brachytherapy - Cancer of Cervix, Cervical Cancer | Phase 3 | Completed | Tata Memorial Hospital | 750 | 1996-05-01 | 2015-05-06 |
Uterine Cervical Neoplasms (5) · Barakat syndrome (1) · Endometrial Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Neoplasms by Site (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Uterine Cervical Diseases (5) · Uterine Diseases (5) · Uterine Neoplasms (5) · Neoplasms (4) · Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Control Groups (2) · Brachytherapy (1) · Cisplatin (1) · Gemcitabine (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Neoadjuvant Therapy (1) · Vaccines, Synthetic (1)
Tata Memorial Hospital (2) · Eli Lilly and Company (1) · Instituto Nacional de Salud Publica, Mexico (1) · Rabin Medical Center (1)
India (3) · Mexico (2) · Argentina (1) · Bosnia and Herzegovina (1) · Israel (1) · Pakistan (1) · Peru (1) · Thailand (1)
Opher Caspi, MD PhD (1) · Shyam K Shrivastava, MD (1) · Shyamkishore J Shrivastava, MD, DNB (RT) (1) · Sudeep Gupta, MD, DM (1)